5. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2024. Available at: http://www.clinicalpharmacology.com. Accessed June 4th, 2024.
- Carisoprodol tablets package insert. Meda Pharmaceuticals, Inc. May 2023.
- Chlorzoxazone tablets package insert. Aurobindo Pharma Limited. September 2023.
- Chlorzoxazone (Lorzone) tablets package insert. Vertical Pharmaceuticals, Inc. September 2023.
- Cyclobenzaprine tablets package insert. Amneal Pharmaceuticals, LLC. December 2023.
- Cyclobenzaprine (Fexmid) tablets package insert. Casper Pharma, LLC. March 2019.
- Cyclobenzaprine (Amrix) extended-release capsule package insert. Cephalon, Inc., April 2024.
- Cyclobenzaprine extended-release capsule package insert. Twi Pharmaceuticals, Inc. May 2019.
- Metaxalone tablets package insert. Amneal Pharmaceuticals, LLC. December 2023.
- Methocarbamol tablets package insert. Camber Pharmaceuticals Inc., April 2021.
- Methocarbamol tablets package insert. Misemer Pharmaceutical. January 2024.
- Orphenadrine extended-release tablet package insert. Sandoz Inc. March 2024.
- Baclofen oral tablet package insert. Advagen Pharma Limited. July 2023.
- Baclofen oral granules (Lyvispah) package insert. Amneal Pharmaceuticals, LLC. April 2023.
- Baclofen oral solution (Ozobax DS) package insert. Metacel Pharmaceuticals, LLC. October 2023.
- Baclofen oral suspension (Fleqsuvy) package insert. Azurity Pharmaceuticals, Inc. April 2024.
- Tizanidine tablets and capsules (Zanaflex) package insert. Covis Pharma US, Inc. November 2021.
- Dantrolene oral capsule package insert. Amneal Pharmaceuticals of New York LLC, December 2023.
- Orphenadrine/ aspirin/ caffeine (Norgesic Forte) combination oral tablet package insert. Poly Pharmaceuticals, Inc. January 2024.
- Orphenadrine/ aspirin/ caffeine combination oral tablets package insert. Atland Pharmaceuticals, LLC. January 2024.
- Reeves RR. Beddingfield JJ. Mack JE. Carisoprodol withdrawal syndrome. Pharmacotherapy. 2004; 24:1804-6.
- Reeves RR, Burke RS, Kose S. Carisoprodol: update on abuse potential and legal status. South Med J. 2012;105(11):619-23.